This learning scenario reviews an essential public health concept and explains its importance to bioethics. Students are asked to think about how social determinants affect them a ...

81% of respondents report their organization responded well to the global, economic, and social challenges of the past few years, but performance gaps remain LRN Corporation, a leader in ethics and ...

LRN Corporation, a leader in ethics and compliance (E&C) solutions, has released its highly anticipated 2026 Ethics & Compliance Program Effectiveness Report, ‘ The Next Leap: Technology, trust, and ...

Hilbert College launches pioneering AI program focused on ethics and leadership Video shows masked, armed subject at Nancy Guthrie's door Snow maps show which states will get hit hardest this week ...

The U.S. Department of Health and Human Services (HHS) is touting a biosurveillance program that has surpassed 1 million voluntary participants, aimed to better detect and respond to potential health ...

Round 16 grants expand youth pathways as the NBA Foundation invests in creative careers and workforce readiness. Alyssa Squires, for NBA.com A NOCCA Foundation culinary student works alongside an ...

Hannah Bentz entered the full-time, in-person Master of Science in Bioethics program at Harvard Medical School with a strong foundation in neuroscience and microbiology, and a growing conviction that ...

SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (BOLD) (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative ...

NEW HAVEN, Conn., Jan. 12, 2026 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization ...

SAB Biotherapeutics ( (SABS)) has provided an update. On December 29, 2025, SAB Biotherapeutics, Inc. entered into a new sales agreement with UBS Securities LLC to establish an at-the-market equity ...

Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...